Two cancer research studies reveal essential role of neutrophils in immunotherapy
5 (291) · $ 9.00 · In stock
Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
Cancer discovery could revive failed treatments for solid tumours
Jumping genes in cancer cells open door to new immunotherapies
Scientists unravel tumor neutrophil complexity, discover
Positive opinion for orphan drug designation for avelumab in
Second-line cetuximab active beyond progression in quadruple wild
Genetic signature may predict response to immunotherapy for non
Chemotherapy for rare cancer fine-tuned with organoids - ecancer
Surprise Finding Shows That Neutrophils Can Be Key Antitumor
Study identifies how microbiome may affect pancreatic cancer
Results from the TAGS study demonstrate safety and efficacy of
Two cancer research studies reveal essential role of neutrophils
ESMO 2016: Ceritinib provides longer PFS than chemo in trial of
Scientists uncover a startling and exploitable coordination of
Patients with refractory metastatic colorectal cancer experience
Turbocharging the killing power of immune cells against cancer
